News & Updates

Show Multimedia Only

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

Immunoprophylaxis with nirsevimab results in a 74-percent decrease in hospitalization and 85-percent reduction in paediatric intensive care unit (PICU) admissions due to respiratory syncytial virus (RSV)-related bronchiolitis, a study has shown.

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025 by

Significant treatment gaps persist in lipid management among individuals at very high cardiovascular risk, with up to 80 percent of patients not achieving their low-density lipoprotein cholesterol (LDL-C) goals, reports a Singapore study.

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025

Add-on metformin of little benefit in advanced stage ovarian cancer

24 Apr 2025

Using metformin in addition to first-line platinum/taxane-based chemotherapy does not appear to produce survival gains in patients with newly diagnosed advanced stage ovarian cancer, according to a study.

Add-on metformin of little benefit in advanced stage ovarian cancer

24 Apr 2025

Obesity may reduce efficacy of psoriasis therapies

23 Apr 2025

A robust association exists between psoriasis and obesity, a recent study has shown.

Obesity may reduce efficacy of psoriasis therapies

23 Apr 2025

Clomipramine-sildenafil combo tied to better outcomes in men with PE

23 Apr 2025 by

The combination regimen of clomipramine and sildenafil led to better outcomes than clomipramine or sildenafil alone in men with premature ejaculation (PE) without erectile dysfunction (ED), according to a study presented at EAU25.

Clomipramine-sildenafil combo tied to better outcomes in men with PE

23 Apr 2025

Switching to tirzepatide reduces HbA1c, weight in adults with T2D

22 Apr 2025

In people with type 2 diabetes (T2D) with inadequate control, switching to tirzepatide results in additional reductions in haemoglobin A1c (HbA1c) and body weight compared with escalating dulaglutide dose, reports a study.

Switching to tirzepatide reduces HbA1c, weight in adults with T2D

22 Apr 2025

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Thromboprophylaxis with low molecular weight heparin (LMWH) appears to protect against the onset of superimposed pre-eclampsia, independently from aspirin use, reports a recent study.

Heparin use may prevent pre-eclampsia onset

22 Apr 2025

Estetrol/drospirenone helps relieve dysmenorrhea

22 Apr 2025

Treatment with estetrol/drospirenone appears to be safe and efficacious in Japanese women with primary and secondary dysmenorrhea, according to a study.